How to continue Wellbutrin after moving to Florida
Share
Written by Klarity Editorial Team
Published: Jun 7, 2026
Table of contents
Share
If you’re struggling with binge eating disorder (BED), you might be wondering whether you can access treatment through telehealth—and specifically, whether medications like Topamax or Wellbutrin can be prescribed online. The short answer is yes, and in most cases, you won’t need an in-person visit to get started.
As of 2025, telehealth has become a well-regulated, accessible pathway for mental health and eating disorder care. This guide breaks down everything you need to know about getting BED medication through online providers, including the legal landscape, safety considerations, and what to expect from your virtual care experience.
Understanding Binge Eating Disorder and Medication Treatment
Binge Eating Disorder is the most common eating disorder in the United States, affecting millions of people who experience recurring episodes of eating large amounts of food while feeling a loss of control. Unlike bulimia, BED doesn’t involve purging behaviors, but it can lead to significant physical and emotional health consequences.
While the only FDA-approved medication for BED is Vyvanse (a controlled stimulant with strict prescribing requirements), healthcare providers commonly prescribe off-label medications that have shown effectiveness in clinical studies:
Topamax (topiramate): Originally approved for seizures and migraines, research suggests it may help reduce binge eating frequency and support impulse control
Wellbutrin (bupropion): FDA-approved for depression and smoking cessation, studies indicate it can decrease binge episodes in some patients
Both medications are non-controlled substances, which makes them significantly more accessible through telehealth than controlled medications.
Free consultations available with select providers only.
Free consultations available with select providers only.
The Legal Framework: Why Telehealth Works for BED Medications
Federal Rules Don’t Restrict Non-Controlled Medications
Here’s the crucial point many patients don’t realize: The federal restrictions on telehealth prescribing only apply to controlled substances. The Ryan Haight Act, which typically requires an in-person visit before prescribing controlled medications, was designed specifically for drugs with abuse potential—primarily opioids and stimulants.
Since Topamax and Wellbutrin are not controlled substances, they’ve never been subject to these federal telehealth restrictions. This means licensed healthcare providers can prescribe them via telehealth following the same standard of care they’d use for any other prescription medication.
The temporary DEA telehealth flexibilities you may have heard about (recently extended through December 31, 2026) primarily address controlled substance prescribing during the pandemic. For non-controlled BED medications, telehealth access has remained consistently available—and will continue to be available regardless of what happens with those temporary rules.
State-by-State Variations
While federal law doesn’t restrict telehealth prescribing of non-controlled medications, individual states set their own standards. The good news? Most states have permanently adopted telehealth-friendly policies that recognize virtual visits as equivalent to in-person care when appropriate.
States with no in-person requirements for non-controlled medications include:
California
Delaware
New York
Texas
Florida
Michigan
Wisconsin
South Carolina
A few states require periodic in-person follow-ups:
Alabama: After four telehealth visits within 12 months for the same condition, an in-person visit is required within one year (this can be with any collaborating provider, not necessarily your telehealth doctor)
Georgia: Requires attempting an annual in-person exam for ongoing telemedicine care
New Hampshire: Allows telehealth initiation but requires an in-person follow-up at least every 12 months for continued treatment
Even in states with periodic in-person requirements, you can start treatment entirely online, and the eventual in-person visit can often be completed at a local clinic coordinated with your telehealth provider.
Who Can Prescribe BED Medications via Telehealth?
Physicians and Advance Practice Providers
Medical doctors (MDs) and doctors of osteopathy (DOs) can prescribe these medications in all states when licensed to practice telehealth in your location.
Nurse Practitioners (NPs) and Physician Assistants (PAs) can also prescribe Topamax and Wellbutrin, though their level of independence varies by state:
Full Practice Authority States (NPs can prescribe independently): As of 2025, approximately 34 states plus Washington, D.C. grant NPs full practice authority. Recent additions include:
Michigan (2025)
Wisconsin (August 2025)
Louisiana (2024)
Kansas (2024)
In these states, an NP can evaluate you, diagnose BED, and prescribe medication without physician oversight.
Collaborative Practice States: In states like Texas, Florida, Georgia, and Alabama, NPs and PAs must work under a collaborative agreement with a physician. This doesn’t affect your care quality—it’s simply a regulatory requirement. You may see both the NP/PA and supervising physician’s names on documentation, but the NP/PA typically handles your direct care.
At Klarity Health, our network includes both physicians and nurse practitioners licensed across multiple states, ensuring you can access qualified care regardless of where you live. Our providers are credentialed to practice telehealth in your specific state and follow all local regulations while offering flexible, affordable treatment options.
What to Expect: The Telehealth Evaluation Process
Initial Assessment
Your first telehealth appointment for BED will typically last 30-45 minutes. A thorough provider will:
Review your eating patterns: Expect detailed questions about:
Frequency and duration of binge eating episodes
What triggers your binges
How you feel during and after episodes
Whether you experience compensatory behaviors (purging, excessive exercise)
Assess DSM-5 criteria: To diagnose BED, providers verify you meet specific criteria:
Recurrent episodes of binge eating (eating an unusually large amount in a discrete period with loss of control)
Episodes occur at least once weekly for three months
Significant distress about binge eating
No regular compensatory behaviors (which would suggest bulimia)
Take a comprehensive medical history:
Current medications and supplements
History of seizures, eating disorders, or mental health conditions
Pregnancy status and contraception use
Substance use, including alcohol
Any contraindications to proposed medications
Discuss treatment options: A quality provider won’t just hand you a prescription. They should explain:
How the medication works for BED
Expected benefits and realistic timelines
Potential side effects and monitoring needs
Why they’re recommending off-label use (since neither drug is FDA-approved specifically for BED)
Complementary treatments like therapy, nutrition counseling, or support groups
Identity and Location Verification
Don’t be surprised when your telehealth provider asks to verify your identity and location. This isn’t invasive—it’s actually a legal requirement in many states to ensure:
The provider is licensed in your state
You’re physically located in a state where they can legally practice
The prescription can be legally filled in your jurisdiction
This verification protects both you and the provider from regulatory issues.
Documentation and Consent
You’ll receive and sign several documents:
Telehealth Consent Form: This outlines:
What telehealth can and cannot do
Technology requirements and troubleshooting
Privacy protections and HIPAA compliance
Emergency procedures if you experience a crisis
Any limitations (for example, most telehealth services won’t prescribe controlled substances)
Treatment Consent: Separate consent for medication, explaining:
The off-label nature of the prescription
Specific risks for the medication being prescribed
Monitoring requirements
What to do if you experience side effects
Privacy Notices: Standard HIPAA authorizations and privacy policies
Take time to read these documents. Reputable providers will answer any questions before you sign.
Safety Considerations and Contraindications
Who Should NOT Get BED Medication via Telehealth
Telehealth is convenient and effective for many people, but it’s not appropriate for everyone. You may not be a candidate for online BED medication if you have:
For Wellbutrin (Bupropion):
Current or past history of bulimia or anorexia nervosa (significantly increases seizure risk—this is a black box contraindication)
History of seizure disorder
Abrupt discontinuation of alcohol or benzodiazepines (seizure risk)
Current MAOI use or use within the past 14 days
For Topamax (Topiramate):
Pregnancy or planning to become pregnant (linked to cleft palate and other birth defects)
Metabolic acidosis
Severe kidney problems
History of kidney stones (topiramate increases risk)
General Telehealth Exclusions:
Severe medical instability requiring urgent in-person evaluation
Active suicidal ideation or intent (requires higher level of care)
Uncontrolled severe psychiatric conditions
Inability to participate in video visits or provide informed consent
History suggesting high risk of medication misuse
A responsible telehealth provider will screen for these factors and refer you to in-person care when appropriate. This isn’t a rejection—it’s ensuring you get the right level of care for your specific situation.
Special Considerations for Women of Childbearing Age
If you can become pregnant, your provider will discuss contraception before prescribing topiramate. The medication carries significant teratogenic risks, particularly in the first trimester. Most providers will:
Confirm you’re using reliable birth control
Discuss what to do if you become pregnant while taking the medication
Document this conversation in your medical record
This isn’t judgment—it’s standard medical care to protect both you and potential pregnancies.
Understanding Off-Label Prescribing
You might feel uncertain when your provider recommends a medication that isn’t FDA-approved specifically for BED. This is completely normal and very common in medicine.
Off-label prescribing is:
Legal and widely practiced
Supported by clinical research and evidence
Part of standard psychiatric and medical care
Carefully documented in your medical record
For BED specifically:
Topiramate has multiple studies showing reduced binge frequency and some weight loss in BED patients
Bupropion research indicates decreased binge episodes and improved mood in patients with comorbid depression
Your provider should clearly explain:
Why they’re recommending this medication
What evidence supports its use
How it compares to other treatment options
That you’re consenting to off-label use
At Klarity Health, our providers take time to explain treatment rationale and ensure you understand both the evidence base and limitations of off-label medications. We believe informed patients make better treatment decisions and have better outcomes.
Medication Management and Follow-Up Care
Starting Your Medication
Titration Strategy: Most providers use a ‘start low, go slow’ approach:
Topiramate: Often starts at 25mg daily, gradually increasing every 1-2 weeks to a target dose (typically 75-200mg daily for BED)
Bupropion: May start at 150mg SR once daily, potentially increasing to 150mg twice daily or 300mg XL once daily
This gradual approach minimizes side effects and helps identify the lowest effective dose.
Monitoring and Check-Ins
Early Follow-Up: Expect:
2-week check-in after starting medication
Monthly appointments for the first 2-3 months
Assessment of side effects, efficacy, and tolerability
Dose adjustments based on your response
Ongoing Care: Once stable:
Appointments every 1-3 months (depending on state requirements and clinical need)
Regular assessment of binge eating frequency
Weight and metabolic monitoring
Evaluation of comorbid symptoms (depression, anxiety)
Periodic review of whether to continue, adjust, or discontinue medication
Changes in taste (especially carbonated beverages)
Kidney stone symptoms
Vision changes
For Bupropion:
Unusual mood changes or agitation
Any seizure activity
Severe headaches
Insomnia or significant sleep changes
Increased anxiety
Your telehealth platform should offer multiple ways to reach your provider between appointments—messaging, nurse triage lines, or urgent visit scheduling.
Prescription Refills
One major advantage of non-controlled medications: easier refill management.
Providers can typically authorize refills for 6-12 months
Electronic prescriptions sent directly to your pharmacy
No monthly prescription requirements (unlike controlled substances)
Ability to use mail-order pharmacies for 90-day supplies
However, refills don’t replace regular appointments. Even with automated refills, you’ll need periodic check-ins to ensure safe, effective treatment.
Insurance Coverage and Costs
Telehealth Parity Laws
Most states now require insurance companies to cover telehealth visits at the same rate as in-person visits. This means:
Your copay should be the same for telehealth as office visits
Insurance cannot require higher cost-sharing for virtual care
Prior authorizations work the same way
Medication Costs
With Insurance:
Both bupropion and topiramate are available as generics, typically covered by insurance
Typical copays: $10-30 for generic versions
Some plans may require prior authorization for off-label use
Without Insurance:
Generic topiramate: $10-40/month
Generic bupropion SR/XL: $10-50/month
GoodRx and similar discount programs can significantly reduce costs
Klarity Health’s Transparent Pricing
At Klarity Health, we accept both insurance and self-pay, with transparent pricing posted upfront. Our model is designed to remove financial barriers to mental health care:
Same-day or next-day appointments available
Clear pricing before you book
No surprise bills
Flexible payment options for those paying out-of-pocket
We believe cost shouldn’t prevent you from getting help for BED, which is why we work to keep both visit fees and medication costs affordable.
Red Flags: What to Avoid in Telehealth Services
The explosion of telehealth has unfortunately included some bad actors. Be cautious of services that:
Guarantee Prescriptions Before Evaluation
Legitimate providers cannot promise a specific medication before assessing you
‘Get your prescription in 15 minutes’ is a red flag
Proper evaluation takes time—usually 30+ minutes for initial BED assessment
Skip Comprehensive Medical History
If you’re only asked 3-4 screening questions, that’s insufficient
Proper care requires detailed history of eating patterns, medical conditions, medications, and contraindications
Video visits should feel like thorough doctor appointments, not quick transactions
Don’t Discuss Alternatives
Medication is just one tool for BED
Quality providers discuss therapy, nutrition counseling, support groups
Be wary of anyone who only offers pills without mentioning other evidence-based treatments
Prescribe Controlled Substances Too Easily
While not your BED medications, if a service freely prescribes stimulants or opioids with minimal evaluation, that’s concerning
It suggests poor safety protocols across all prescribing
Have Unclear Licensing or Provider Information
You should easily find your provider’s name, credentials, and license number
Providers must be licensed in your state
Avoid services that are vague about who will see you
Pressure You to Buy Medication Directly From Them
Legitimate services send prescriptions to regular pharmacies
If a site wants to sell you medication directly (not through a licensed pharmacy), that’s a major red flag
You should be able to fill prescriptions at any pharmacy you choose
Combining Medication with Other BED Treatments
Medication alone rarely ‘cures’ BED. The most effective approach typically combines:
Evidence-Based Psychotherapy
Cognitive Behavioral Therapy (CBT): The gold standard for BED treatment:
Helps identify triggers and thought patterns
Develops coping strategies
Addresses underlying beliefs about food, weight, and self-worth
Interpersonal Therapy (IPT): Addresses relationship and life stressors that may contribute to binge eating
Nutritional Counseling
Working with a registered dietitian can help:
Normalize eating patterns
Reduce restrictive dieting (which often triggers binges)
Develop meal planning skills
Address nutritional deficiencies
Establish regular eating schedules
Many telehealth platforms now offer integrated nutrition services—look for providers who can coordinate medical and nutritional care.
Support Groups and Peer Support
Eating Disorders Anonymous
Overeaters Anonymous
Online BED support communities
Hospital or clinic-based support groups (increasingly offered virtually)
Klarity Health can connect you with complementary resources including therapy referrals and nutritionist recommendations, recognizing that comprehensive BED treatment goes beyond medication.
The Current Regulatory Landscape (2025-2026)
Federal Status
For Non-Controlled Medications (Topamax, Wellbutrin):
No federal restrictions on telehealth prescribing
These medications were never subject to Ryan Haight Act limitations
No changes expected regardless of DEA rule updates
For Controlled Substances:
DEA extended COVID-era telehealth flexibilities through December 31, 2026
Allows initial controlled substance prescribing via telehealth without in-person visit
After 2026, new DEA rules will take effect (details still being finalized)
This affects stimulants like Vyvanse (FDA-approved for BED) but not your non-controlled options
Recent State Changes
Expanded Access:
Wisconsin (August 2025): NPs gained independent practice authority
Michigan (2025): Implemented full NP practice authority
New Hampshire (August 2025): Removed restrictions on telehealth prescribing of Schedule II-IV drugs (with annual in-person follow-up)
Delaware (July 2025): Clarified that telemedicine is allowed for medication-assisted treatment of opioid use disorder
New Restrictions (for controlled substances only):
New York (May 2025): Adopted rule requiring in-person exam before prescribing controlled substances once federal waiver expires (doesn’t affect non-controlled BED meds)
What This Means for You
For BED treatment with non-controlled medications, the regulatory environment is stable and favorable. The temporary nature of some COVID-era rules primarily affects controlled substance prescribing. Your access to topiramate and bupropion via telehealth is not expected to change.
Taking the Next Step: How to Get Started
Choose a Reputable Telehealth Provider
Look for services that:
Clearly state licensing and credentials
Offer comprehensive initial evaluations
Discuss multiple treatment options
Have transparent pricing
Provide ongoing care, not just one-time prescriptions
Can coordinate with your existing healthcare providers
Prepare for Your First Appointment
Gather Information:
Current medication list (including supplements)
Relevant medical history
Insurance information
Pharmacy preference
List of questions or concerns
Track Your Symptoms:
Keep a brief log of binge episodes for 1-2 weeks before your appointment
Note triggers, frequency, and feelings associated with binges
This helps your provider understand your specific pattern
Consider Your Goals:
What do you hope to gain from treatment?
What has or hasn’t worked in the past?
What concerns do you have about medication?
Are you willing to combine medication with therapy?
What Happens After Your First Visit
If medication is appropriate, your provider will:
Send a prescription electronically to your pharmacy
Schedule follow-up appointments
Provide clear instructions on taking the medication
Give you contact information for questions or concerns
Discuss what to do in case of side effects
Most people start noticing effects within 2-4 weeks, though full benefits may take 8-12 weeks. Patience and regular communication with your provider are key.
The Bottom Line: Telehealth for BED Is Accessible and Legitimate
As of 2025, telehealth has evolved from a pandemic emergency measure to a well-regulated, standard option for healthcare delivery. For Binge Eating Disorder specifically:
✅ Telehealth prescribing of non-controlled BED medications is legal nationwide
✅ Most states don’t require in-person visits for non-controlled prescriptions
✅ Licensed providers (MDs, DOs, NPs, PAs) can evaluate and treat BED via video visits
✅ Quality telehealth services follow the same standards of care as in-person treatment
✅ Medications like Topamax and Wellbutrin remain accessible regardless of changes to controlled substance rules
The key is choosing a reputable provider who takes time to understand your specific situation, offers comprehensive evaluation, and provides ongoing care—not just quick prescriptions.
If you’ve been hesitant to seek help for BED because of barriers to in-person care—whether location, schedule, stigma, or access issues—telehealth offers a legitimate pathway to evidence-based treatment. With proper evaluation, appropriate medication, and ideally complementary therapies, many people with BED find significant relief and improved quality of life.
Ready to explore your treatment options? Klarity Health offers comprehensive BED evaluations with licensed providers who can assess whether medication is right for you. With same-day or next-day appointments, transparent pricing, and acceptance of both insurance and self-pay, we’ve removed the barriers that keep too many people from getting help. Our providers are available across multiple states and specialize in eating disorders and mental health treatment delivered with empathy and expertise.
You don’t have to struggle with binge eating alone, and you don’t have to wait weeks for an in-person appointment. Effective, accessible treatment is available now through legitimate telehealth services—and it might be exactly what you need to start your recovery journey.
Research Currency Statement
Verified as of: January 4, 2026
Top 5 Citations
U.S. Department of Health and Human Services Press Release (January 2, 2026) – DEA Extends Telehealth Prescribing Flexibilities Through December 31, 2026. Available at: https://www.hhs.gov/press-room/dea-telemedicine-extension-2026.html
Sheppard Mullin Healthcare Law Blog (August 2025) – ‘Telehealth and In-Person Visits: Tracking Federal and State Updates to Pandemic-Era Telehealth Exceptions.’ Available at: https://www.sheppardhealthlaw.com/2025/08/articles/telehealth/telehealth-and-in-person-visits-tracking-federal-and-state-updates-to-pandemic-era-telehealth-exceptions/
Center for Connected Health Policy (November-December 2025) – State Telehealth Policy Database, Online Prescribing Section. Available at: https://www.cchpca.org/topic/online-prescribing/
Health Jobs Nationwide (2025) – ‘State-by-State Guide: Expanding Roles for PAs and NPs (Updated 2025).’ Available at: https://blog.healthjobsnationwide.com/state-by-state-guide-expanding-roles-for-pas-and-nps-updated-2025/
National Law Review (2025) – ‘Telehealth and In-Person Visits: Tracking Federal and State Updates to Pandemic-Era Telehealth Exceptions.’ Available at: https://natlawreview.com/article/telehealth-and-person-visits-tracking-federal-and-state-updates-pandemic-era
Verification Notes:
80%+ of sources are from 2025 or updated to reflect 2025 regulations
Federal DEA status verified through official HHS announcements (January 2026)
State regulations verified through official medical/nursing board guidance and legislative updates
Temporary vs. permanent policy distinctions clearly documented
Alabama and South Carolina NP scope changes flagged for ongoing monitoring as legislation status remains pending final confirmation